{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:00:51Z","timestamp":1789707651495,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1124\/jpet.120.000457","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T17:11:46Z","timestamp":1611853906000},"page":"169-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Organic Anion\u2013Transporting Polypeptide 1B1\/1B3\u2013Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro\u2013In Vivo Evaluation in Cynomolgus Monkey"],"prefix":"10.1016","volume":"377","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-3967","authenticated-orcid":false,"given":"Heather","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-an","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwoo","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Kosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Tess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-756X","authenticated-orcid":false,"given":"Amit S.","family":"Kalgutkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-6329","authenticated-orcid":false,"given":"Manthena V.S.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.000457_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/17425255.2020.1749595","article-title":"Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?","volume":"16","author":"Alluri","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.120.000457_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.119.257600","article-title":"Quantitative contribution of six major transporters to the hepatic uptake of drugs: \u201cSLC-phenotyping\u201d using primary human hepatocytes","volume":"370","author":"Bi","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/dmd.120.000134","article-title":"Effect of human plasma on hepatic uptake of organic anion-transporting polypeptide 1B substrates: studies using transfected cells and primary human hepatocytes","volume":"49","author":"Bi","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1208\/s12248-017-0051-2","article-title":"Reliable rate measurements for active and passive hepatic uptake using plated human hepatocytes","volume":"19","author":"Bi","year":"2017","journal-title":"AAPS J"},{"key":"10.1124\/jpet.120.000457_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejps.2018.08.008","article-title":"An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation","volume":"123","author":"Bowman","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40262-014-0222-6","article-title":"Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir","volume":"54","author":"Brennan","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.120.000457_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/17425255.2019.1640679","article-title":"The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs","volume":"15","author":"Bteich","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.120.000457_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.120.000457_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1124\/dmd.115.063347","article-title":"Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans","volume":"43","author":"Chu","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.120.000457_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/dmd.118.081315","article-title":"Predicting human clearance of organic anion transporting polypeptide substrates using cynomolgus monkey: in vitro-in vivo scaling of hepatic uptake clearance","volume":"46","author":"De Bruyn","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib13","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1124\/dmd.113.054031","article-title":"A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development","volume":"41","author":"Di","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib14","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1002\/jps.22674","article-title":"Development of a new permeability assay using low-efflux MDCKII cells","volume":"100","author":"Di","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib15","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1101\/gr.123117.111","article-title":"Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment","volume":"21","author":"Ebeling","year":"2011","journal-title":"Genome Res"},{"key":"10.1124\/jpet.120.000457_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/dmd.117.080044","article-title":"Navigating transporter sciences in pharmacokinetics characterization using the extended clearance classification system","volume":"46","author":"El-Kattan","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1208\/s12248-009-9102-7","article-title":"Effects of drug transporters on volume of distribution","volume":"11","author":"Grover","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.120.000457_bib18","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.23202","article-title":"Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs","volume":"101","author":"Hallifax","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0091270009333209","article-title":"Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches","volume":"49","author":"Hosea","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.120.000457_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00498250903003135","article-title":"Cynomolgus monkey CYPs: a comparison with human CYPs","volume":"39","author":"Iwasaki","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.120.000457_bib22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1021\/jm400164c","article-title":"Discovery of danoprevir (ITMN-191\/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3\/4A protease","volume":"57","author":"Jiang","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000457_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/dmd.111.042994","article-title":"Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data","volume":"40","author":"Jones","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/dmd.118.083733","volume":"47","author":"Kim","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib25","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.xphs.2017.04.043","article-title":"Hepatobiliary clearance prediction: species scaling from monkey, dog, and rat, and In Vitro-In Vivo extrapolation of sandwich-cultured human hepatocytes using 17 drugs","volume":"106","author":"Kimoto","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib26","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/dmd.118.081794","article-title":"Simultaneous assessment of transporter-mediated drug-drug interactions using a probe drug cocktail in cynomolgus monkey","volume":"46","author":"Kosa","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1124\/dmd.120.000163","article-title":"In vitro hepatic uptake in human and monkey hepatocytes in the presence and absence of serum protein and its in vitro to in vivo extrapolation","volume":"48","author":"Liang","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/00498254.2018.1512017","article-title":"Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans","volume":"49","author":"Liao","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.120.000457_bib29","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1124\/dmd.112.046193","article-title":"Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes","volume":"40","author":"M\u00e9nochet","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/dmd.117.077115","article-title":"The phenomenon of albumin-mediated hepatic uptake of organic anion transport polypeptide substrates: prediction of the in vivo uptake clearance from the in vitro uptake by isolated hepatocytes using a facilitated-dissociation model","volume":"46","author":"Miyauchi","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib31","first-page":"1359","article-title":"Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol","volume":"25","author":"Obach","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138920008786485119","article-title":"Permeability for intestinal absorption: caco-2 assay and related issues","volume":"9","author":"Press","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/jpet.120.000457_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12377","article-title":"Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin","volume":"78","author":"Prueksaritanont","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.120.000457_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/dmd.117.079152","article-title":"Comparison of species and cell-type differences in fraction unbound of liver tissues, hepatocytes, and cell lines","volume":"46","author":"Riccardi","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/dmd.118.085639","article-title":"A novel unified approach to predict human hepatic clearance for both enzyme- and transporter-mediated mechanisms using suspended human hepatocytes","volume":"47","author":"Riccardi","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib36","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11095-006-9210-3","article-title":"Mechanistic approaches to volume of distribution predictions: understanding the processes","volume":"24","author":"Rodgers","year":"2007","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.120.000457_bib37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.xphs.2019.10.060","article-title":"Evaluation of fraction unbound across 7 tissues of 5 species","volume":"109","author":"Ryu","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1124\/dmd.114.057976","article-title":"Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins","volume":"42","author":"Salphati","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib39","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/jps.21287","article-title":"Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers","volume":"97","author":"Shalaeva","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.120.000457_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.116.232066","article-title":"Coproporphyrins I and III as functional markers of OATP1B activity: in vitro and in vivo evaluation in preclinical species","volume":"357","author":"Shen","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/jpet.114.221804","article-title":"Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys","volume":"353","author":"Shen","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.112.200691","article-title":"Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation","volume":"344","author":"Shen","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib43","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"Volume of distribution in drug design","volume":"58","author":"Smith","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000457_bib44","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1021\/acs.molpharmaceut.0c00444","article-title":"Cytochrome-P450-mediated drug-drug interactions of substrate drugs: assessing clinical risk based on molecular properties and an extended clearance classification system","volume":"17","author":"Steyn","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.120.000457_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.2042-7158.1990.tb05373.x","article-title":"An improved method for the determination of distribution coefficients","volume":"42","author":"Stopher","year":"1990","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.120.000457_bib46","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1124\/dmd.113.052753","article-title":"Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys","volume":"41","author":"Takahashi","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib47","doi-asserted-by":"crossref","first-page":"11831","DOI":"10.1021\/acs.jmedchem.0c01033","article-title":"Predicting the human hepatic clearance of acidic and zwitterionic drugs","volume":"63","author":"Tess","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.120.000457_bib48","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1124\/dmd.117.075275","article-title":"Leveraging of rifampicin-dosed cynomolgus monkeys to identify bile acid 3-O-sulfate conjugates as potential novel biomarkers for organic anion-transporting polypeptides","volume":"45","author":"Thakare","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.118.247767","article-title":"In vitro-in vivo extrapolation of OATP1B-mediated drug-drug interactions in cynomolgus monkey","volume":"365","author":"Ufuk","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/jpet.114.215970","article-title":"Quantitative prediction of transporter- and enzyme-mediated clinical drug-drug interactions of organic anion-transporting polypeptide 1B1 substrates using a mechanistic net-effect model","volume":"351","author":"Varma","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cpt.595","article-title":"Extended Clearance Classification System (ECCS) informed approach for evaluating investigational drugs as substrates of drug transporters","volume":"102","author":"Varma","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.120.000457_bib52","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/mp2004912","article-title":"pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery","volume":"9","author":"Varma","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.120.000457_bib53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cpt.520","article-title":"Transporter-mediated hepatic uptake plays an important role in the pharmacokinetics and drug-drug interactions of montelukast","volume":"101","author":"Varma","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.120.000457_bib54","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.120.000457_bib55","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.108.146647","article-title":"Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans","volume":"328","author":"Watanabe","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.120.000457_bib56","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1124\/dmd.117.077040","article-title":"Clearance prediction methodology needs fundamental improvement: trends common to rat and human hepatocytes\/microsomes and implications for experimental methodology","volume":"45","author":"Wood","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.120.000457_bib57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/clpt.2008.186","article-title":"Elucidating rifampin\u2019s inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite","volume":"85","author":"Zheng","year":"2009","journal-title":"Clin Pharmacol Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.000457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:01:54Z","timestamp":1739973714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022356524270506"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.000457","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic Anion\u2013Transporting Polypeptide 1B1\/1B3\u2013Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro\u2013In Vivo Evaluation in Cynomolgus Monkey","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.000457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}